[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100526566":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":31,"responsibleParty":66,"collaborators":20,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":70,"sex":75,"minAge":76,"maxAge":77,"enrollmentInfo":78,"targetDuration":20,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":90,"overallStatus":34,"whyStopped":20,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Centre Hospitalier Universitaire de Nice","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"deucravacitinib treatment","EXPERIMENTAL","challenge-dechallenge -rechallenge design",[13],"Drug: deucravacitinib",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","deucravacitinib","treatment by deucravacitinib in two phases of challenge",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Christine Chiaverini","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"christine chiaverini","CONTACT","04.92.03.47.02","chiaverini.c@chu-nice.fr",[32,51],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"CHU de Nice","RECRUITING","Nice","CHU de NICE","06003","France","FR",{"type":41,"coordinates":42},"Point",[43,44],7.26608,43.70313,{"lat":44,"lon":43},[47,49],{"name":20,"role":28,"phone":48,"phoneExt":20,"email":20},"0492034702",{"name":50,"role":24,"phone":20,"phoneExt":20,"email":20},"Christine CHIAVERINI",{"facility":52,"status":34,"city":53,"state":38,"zip":54,"country":38,"countryCode":39,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"APHP St Louis","Paris","75010",{"type":41,"coordinates":56},[57,58],2.3488,48.85341,{"lat":58,"lon":57},[61,65],{"name":62,"role":28,"phone":63,"phoneExt":20,"email":64},"Emmanuelle BOURRAT, Doctor","01 42 49 45 41","marioncauseret@yahoo.fr",{"name":62,"role":24,"phone":20,"phoneExt":20,"email":20},{"type":67,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100526566","phase-2-a-44-week-monocentric-open-study-assessing-the-efficacy-and-safety-of-deucravacitinib-in-adults-with-inflammatory-genodermatoses-100526566",false,"NCT06136403","A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses","GENEPID","Inclusion Criteria:\n\n* Subject has congenital skin fragility with skin and\u002For mucosal blisters, a clinical phenotype of EBS-sev and a laboratory confirmed diagnosis of EBS by KRT5 and\u002For 14 mutation (autosomal only) OR a clinical phenotype of inflammatory ichthyosis (IC) including keratinopathic ichthyosis due to KRT1\u002F10 mutation, ECI with identified genetic mutations (TGM5, NIPAL4, ABCA12, etc…).\n* Subject has at least a mean daily number of 4 new blisters (EBS-sev) OR an ISS \\> 50\u002F128.\n\n  * Subject agrees not to use any topical therapies other than the investigator approved.\n\nExclusion Criteria:\n\n* Subjects with another form of ICI ie Netherton syndrome, Kid syndrome etc.\n* Infectious\u002FImmune-related Exclusions\n* Medical History and Concurrent Diseases","ALL","18 Years","99 Years",{"count":79,"type":80},10,"ESTIMATED","INTERVENTIONAL",[83],"PHASE2","The goal of this clinical trial is to learn about deucravacitinib treatment in adults with inflammatory epidermal genodermatoses . The main question it aims to answer are: describe efficacity and safety of this treatment.\n\nParticipants will take treatments and have to use bullets during the study period.",[86,87,88,89],"Epidermolysis Bullosa Simplex","Ichthyosis","Genodermatosis","Inflammatory Congenital Ichthyoses",[17],"2025-07-31",{"date":93,"type":94},"2025-08-05","ACTUAL",{"date":96,"type":94},"2024-03-18",{"date":98,"type":80},"2026-10-12",{"name":5,"class":6},2]